---
title: "Sonnet BioTherapeutics Holdings, Inc. Adjourns Special Meeting for Business Combination Vote"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/266402921.md"
description: "Sonnet BioTherapeutics Holdings, Inc. has adjourned its special meeting to December 2, 2025, to allow more time for voting on a business combination. Over 95% of shares voted support the combination, and HSI's shares are approved for Nasdaq listing post-transaction. The board recommends stockholders vote in favor of all proposals. The meeting is accessible online for stockholders of record as of October 20, 2025."
datetime: "2025-11-18T14:25:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266402921.md)
  - [en](https://longbridge.com/en/news/266402921.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266402921.md)
generator: "portal-rs"
---

# Sonnet BioTherapeutics Holdings, Inc. Adjourns Special Meeting for Business Combination Vote

**On November 18, 2025, Sonnet BioTherapeutics Holdings, Inc. announced the adjournment of its special meeting to allow more time for voting on a business combination.**

**Key Highlights:**

-   Special meeting adjourned to December 2, 2025, for additional voting time.
-   Over 95% of shares voted so far support the business combination.
-   HSI's shares approved for Nasdaq listing post-transaction.
-   Board recommends stockholders vote in favor of all proposals.
-   Meeting accessible online for stockholders of record as of October 20, 2025.

Original SEC Filing: Sonnet BioTherapeutics Holdings, Inc. \[ SONN \] - 8-K - Nov. 18, 2025

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [SONN.US](https://longbridge.com/en/quote/SONN.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**